showed a trendp = 0.078
SB203580 showed a trend toward reducing the remaining STAT1 activation ( p = 0.078), whereas the addition of the Src inhibitor saracatinib further suppressed it almost completely ( Fig. 3 , I and J ).
SB203580 showed a trend toward reducing the remaining STAT1 activation ( p = 0.078), whereas the addition of the Src inhibitor saracatinib further suppressed it almost completely ( Fig. 3 , I and J ).